Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Abstract 3552: JAK/Stat3 signaling pathway modulates human megakaryocytic differentiation

View through CrossRef
Abstract Megakaryocytes (MKs) are differentiated from pluripotent hematopoietic stem cells toward a lineage capable of terminal differentiation to mature platelets. Various hematopoietic growth factors such as thrombopoietin, the ligand of c-mpl-encoded protein, have been identified as important regulators of MK development. Induction of MK differentiation may benefit disorders related to platelet dysfunction or thrombocytopenia. However, both effective inducer and clear mechanism of MK differentiation remain lacking. To clarify the regulatory mechanisms of MK differentiation, distinct inducers staurosporine (STS) and 12-O-Tetradecanoylphorbol-13-acetate (TPA) were used to assess the expression of Janus kinase (JAK) and Signal transducers and activators of transcription 3 (Stat3) signaling molecules in both human chronic myeloid leukemia K562 and erythroleukemia HEL cells. Our results demonstrated that STS and TPA effectively induced cell differentiation toward MK lineage in terms of development of polyploidy population, expression of MK-specific markers CD41 and CD61, and secretion of platelet factor 4. Intriguingly, enhancement in phosphorylation of Stat3 (p-Stat3), nuclear translocation and DNA-binding activity was evident in both STS- and TPA-treated cells. Blockade of Stat3 by Stat3 inhibitor VI and its upstream molecule JAK by JAK inhibitor I obviously declined MK differentiation. Furthermore, knockdown of Stat3 by RNA interference attenuated the expression of p-Stat3 and MK differentiation, indicating a crucial role of Stat3 in MK differentiation. In conclusion, JAK/Stat3 signaling pathway may involve MK differentiation and might be a target for development of therapeutic modulators for platelet disorders. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 3552. doi:10.1158/1538-7445.AM2011-3552
American Association for Cancer Research (AACR)
Title: Abstract 3552: JAK/Stat3 signaling pathway modulates human megakaryocytic differentiation
Description:
Abstract Megakaryocytes (MKs) are differentiated from pluripotent hematopoietic stem cells toward a lineage capable of terminal differentiation to mature platelets.
Various hematopoietic growth factors such as thrombopoietin, the ligand of c-mpl-encoded protein, have been identified as important regulators of MK development.
Induction of MK differentiation may benefit disorders related to platelet dysfunction or thrombocytopenia.
However, both effective inducer and clear mechanism of MK differentiation remain lacking.
To clarify the regulatory mechanisms of MK differentiation, distinct inducers staurosporine (STS) and 12-O-Tetradecanoylphorbol-13-acetate (TPA) were used to assess the expression of Janus kinase (JAK) and Signal transducers and activators of transcription 3 (Stat3) signaling molecules in both human chronic myeloid leukemia K562 and erythroleukemia HEL cells.
Our results demonstrated that STS and TPA effectively induced cell differentiation toward MK lineage in terms of development of polyploidy population, expression of MK-specific markers CD41 and CD61, and secretion of platelet factor 4.
Intriguingly, enhancement in phosphorylation of Stat3 (p-Stat3), nuclear translocation and DNA-binding activity was evident in both STS- and TPA-treated cells.
Blockade of Stat3 by Stat3 inhibitor VI and its upstream molecule JAK by JAK inhibitor I obviously declined MK differentiation.
Furthermore, knockdown of Stat3 by RNA interference attenuated the expression of p-Stat3 and MK differentiation, indicating a crucial role of Stat3 in MK differentiation.
In conclusion, JAK/Stat3 signaling pathway may involve MK differentiation and might be a target for development of therapeutic modulators for platelet disorders.
Citation Format: {Authors}.
{Abstract title} [abstract].
In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL.
Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 3552.
doi:10.
1158/1538-7445.
AM2011-3552.

Related Results

Abstract 1404: Novel STAT3 inhibitors targeting the STAT3 dimerization
Abstract 1404: Novel STAT3 inhibitors targeting the STAT3 dimerization
Abstract Background The STAT3 pathway may drive prostate cancer (PCa) progression to metastatic castration-resistant prostate cancer (mCRPC). STAT3 may serve as a go...
Abstract 1705: 3D growth modulates the competition between STAT3 and STAT5 in breast cancer
Abstract 1705: 3D growth modulates the competition between STAT3 and STAT5 in breast cancer
Abstract Approximately 13% of women are diagnosed with invasive breast cancer. Signal Transducer and Activator of Transcription 3 (STAT3) is a transcription factor t...
STAT3 Protein–Protein Interaction Analysis Finds P300 as a Regulator of STAT3 and Histone 3 Lysine 27 Acetylation in Pericytes
STAT3 Protein–Protein Interaction Analysis Finds P300 as a Regulator of STAT3 and Histone 3 Lysine 27 Acetylation in Pericytes
Background: Signal transducer and activator of transcription 3 (STAT3) is a member of the cytoplasmic inducible transcription factors and plays an important role in mediating signa...
STAT3 Mutations in Large Granular Lymphocytic Leukemia
STAT3 Mutations in Large Granular Lymphocytic Leukemia
Abstract Abstract 1606 Introduction: Large granular lymphocytic leukemia (LGL leukemia) is a rare lymphoprolifera...
Loss of Stat3 in Osteoblasts Impaired the Bone Remodeling in Inflammatory Microenvironment
Loss of Stat3 in Osteoblasts Impaired the Bone Remodeling in Inflammatory Microenvironment
Abstract Introduction: Oral diseases including periodontitis, periapical periodontitis, and peri-implantitis are characterized by inflammation and loss of alveolar bone. Si...
Abstract 5051: STAT3 signaling activates MSK1-mediated histone H3 phosphorylation in N-nitrosocompounds induced carcinogenesis
Abstract 5051: STAT3 signaling activates MSK1-mediated histone H3 phosphorylation in N-nitrosocompounds induced carcinogenesis
Abstract Signal transducer and activator of transcription (STATs) signaling, particularly STAT3, have been demonstrated to be one of the central pathways for cancer ...

Back to Top